Interferon α-2b treatment in a murine model for metastatic ocular melanoma.

被引:0
|
作者
Dithmar, S
Rusciano, D
Lawson, DH
Grossniklaus, HE
机构
[1] Emory Univ, Sch Med, Dept Ophthalmol, Atlanta, GA 30322 USA
[2] Emory Univ, Sch Med, Dept Med, Atlanta, GA 30322 USA
[3] Friedrich Miescher Inst, CH-4002 Basel, Switzerland
[4] Univ Heidelberg, Dept Ophthalmol, D-6900 Heidelberg, Germany
关键词
D O I
暂无
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
568
引用
收藏
页码:S110 / S110
页数:1
相关论文
共 50 条
  • [21] INTERMEDIATE DOSE INTERFERON ALFA 2B (IFN ALFA 2B) IN ADJUVANT TREATMENT OF MALIGNANT MELANOMA
    Calabria, Caterina
    Savio, Giuseppina
    Laudani, Agata
    Leonardi, Vita
    Blasi, Livio
    Stefano, Rosalba
    Agostara, Biagio
    ANNALS OF ONCOLOGY, 2004, 15 : 88 - 89
  • [22] Intermediate dose interferon alpha 2b (IFN alpha 2b) in adiuvant treatment for Malignant Melanoma
    Savio, G.
    Calabria, C.
    Leonardi, V.
    Laudani, A.
    Pepe, A.
    Blasi, L.
    Usset, A.
    Rondello, G.
    Agostara, B.
    ANNALS OF ONCOLOGY, 2005, 16 : 171 - 171
  • [23] Newcastle Disease Virus oncolysate treatment of metastatic ocular melanoma in a murine model.
    Adams, AW
    Dithmar, S
    Dodson, DD
    Yang, H
    Bonaccorsi, P
    Ansel, JC
    Grossniklaus, HE
    Armstrong, CA
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2000, 41 (04) : S385 - S385
  • [24] Adjuvant Topical Interferon Alpha 2b for the Treatment of Monkeypox Ocular Manifestations
    Arteaga-Rivera, Jose Y.
    Vigderovich-Cielak, Itamar
    Ramirez-Miranda, Arturo
    Gonzalez, Andrea
    Frias-Jimenez, Emmanuel
    Arriaga-Guzman, Ivonne E.
    Sierra Madero, Juan G.
    Navas, Alejandro
    Graue-Hernandez, Enrique O.
    CORNEA, 2023, 42 (12) : 1578 - 1581
  • [25] Interferon α-2b decreases hepatic micrometastasis from ocular melanoma by activation of NK cells
    Grossniklaus, HE
    Yang, H
    Dithmar, S
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2003, 44 : U367 - U367
  • [26] Intraperitoneal and subcutaneous treatment of experimental endometriosis with recombinant human interferon-α-2b in a murine model
    Ingelmo, JMR
    Quereda, F
    Acién, P
    FERTILITY AND STERILITY, 1999, 71 (05) : 907 - 911
  • [27] Treatment with vemurafenib in patients with metastatic melanoma.
    Ocvirk, Janja
    Boc, Marko
    Mesti, Tanja
    Rebersek, Martina
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [28] Metastatic uveal melanoma. Prophylaxis and treatment
    Bechrakis, NE
    Scheibenbogen, C
    Schmittel, A
    Servetopoulou, F
    Foerster, MH
    Keilholz, U
    OPHTHALMOLOGE, 2002, 99 (05): : 333 - 337
  • [29] Fotemustine, dacarbazine (DTIC) and interferon alpha-2A (IFN) treatment of metastatic melanoma. Preliminary data
    Comella, P
    Presutti, F
    Daponte, A
    Casaretti, R
    Frasci, G
    Palmieri, G
    Gargiulo, R
    Annunziata, M
    Balasco, A
    Perchard, J
    Comella, G
    EUROPEAN JOURNAL OF CANCER, 1995, 31A : 214 - 214
  • [30] A Phase 2 Trial of Bevacizumab and High-dose Interferon Alpha 2B in Metastatic Melanoma
    Grignol, Valerie P.
    Olencki, Thomas
    Relekar, Kiran
    Taylor, Cynthia
    Kibler, Amanda
    Kefauver, Cheryl
    Wei, Lai
    Walker, Michael J.
    Chen, Helen X.
    Kendra, Kari
    Carson, William E., III
    JOURNAL OF IMMUNOTHERAPY, 2011, 34 (06) : 509 - 515